Literature DB >> 10700212

Malaria transmission-blocking vaccines--how can their development be supported?

R Carter1, K N Mendis, L H Miller, L Molineaux, A Saul.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10700212     DOI： 10.1038/73062

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  48 in total

1.  Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax.

Authors:  Masanori Doi; Kazuyuki Tanabe; Shin-Ichiro Tachibana; Meiko Hamai; Mayumi Tachibana; Toshihiro Mita; Masanori Yagi; Fadile Yildiz Zeyrek; Marcelo U Ferreira; Hiroshi Ohmae; Akira Kaneko; Milijaona Randrianarivelojosia; Jetsumon Sattabongkot; Ya-Ming Cao; Toshihiro Horii; Motomi Torii; Takafumi Tsuboi
Journal:  Vaccine       Date:  2011-04-21       Impact factor: 3.641

2.  Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex.

Authors:  Yimin Wu; Craig Przysiecki; Elizabeth Flanagan; Sheila N Bello-Irizarry; Roxana Ionescu; Olga Muratova; Gelu Dobrescu; Lynn Lambert; David Keister; Yvette Rippeon; Carole A Long; Li Shi; Michael Caulfield; Alan Shaw; Allan Saul; John Shiver; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-16       Impact factor: 11.205

3.  Sequence polymorphisms in Pvs48/45 and Pvs47 gametocyte and gamete surface proteins in Plasmodium vivax isolated in Korea.

Authors:  Mi Kyung Woo; Kyeong Ah Kim; JuYeon Kim; Jun Seo Oh; Eun Taek Han; Seong Soo A An; Chae Seung Lim
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

Review 4.  Platform for Plasmodium vivax vaccine discovery and development.

Authors:  Sócrates Herrera Valencia; Diana Carolina Rodríguez; Diana Lucía Acero; Vanessa Ocampo; Myriam Arévalo-Herrera
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

Review 5.  Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America.

Authors:  Myriam Arévalo-Herrera; Yezid Solarte; Catherin Marin; Mariana Santos; Jenniffer Castellanos; John C Beier; Sócrates Herrera Valencia
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

6.  Interspecific competition during transmission of two sympatric malaria parasite species to the mosquito vector.

Authors:  Rick E L Paul; Van Anh Ton Nu; Antoniana U Krettli; Paul T Brey
Journal:  Proc Biol Sci       Date:  2002-12-22       Impact factor: 5.349

7.  Apical surface expression of aspartic protease Plasmepsin 4, a potential transmission-blocking target of the plasmodium ookinete.

Authors:  Fengwu Li; Kailash P Patra; Charles A Yowell; John B Dame; Karen Chin; Joseph M Vinetz
Journal:  J Biol Chem       Date:  2010-01-07       Impact factor: 5.157

8.  Suppressive effect of azithromycin on Plasmodium berghei mosquito stage development and apicoplast replication.

Authors:  Shoichi Shimizu; Yoshio Osada; Tamotsu Kanazawa; Yoshiya Tanaka; Meiji Arai
Journal:  Malar J       Date:  2010-03-10       Impact factor: 2.979

9.  Heritability of the human infectious reservoir of malaria parasites.

Authors:  Yaye Ramatoulaye Lawaly; Anavaj Sakuntabhai; Laurence Marrama; Lassana Konate; Waraphon Phimpraphi; Cheikh Sokhna; Adama Tall; Fatoumata Diène Sarr; Chayanon Peerapittayamongkol; Chalisa Louicharoen; Bradley S Schneider; Anaïs Levescot; Arthur Talman; Isabelle Casademont; Didier Menard; Jean-François Trape; Christophe Rogier; Jaranit Kaewkunwal; Thanyachai Sura; Issarang Nuchprayoon; Frederic Ariey; Laurence Baril; Pratap Singhasivanon; Odile Mercereau-Puijalon; Rick Paul
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

10.  A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli.

Authors:  Debabani Roy Chowdhury; Evelina Angov; Thomas Kariuki; Nirbhay Kumar
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.